Skip to main content
. Author manuscript; available in PMC: 2013 Aug 1.
Published in final edited form as: Infect Control Hosp Epidemiol. 2012 Jun 26;33(8):849–852. doi: 10.1086/666629

Table 2.

Factors Associated with Additional Reported Time-to-bed-assignment and Polices for Discontinuation of Contact Precautions for Patients with a History of MRSA and VRE.

MRSA Time-to-bed-assignment Discontinuation Policy
Factor (N)a Minutes
Adjustedb
Adjusted
OR (95%CI)c
PAM with >5 years of experience (N=149/231) 6.1 --
Large institution (N=88/230) 7.5 1.8 (0.8–3.7)
Urban setting (N=144/233) 4.0 0.7 (0.3–1.4)
Cohorting patients permitted (N=60/215) 12.6* 2.8 (1.3–6.0)**
Mixed or double occupancy (N=158/231) 8.2 1.0 (0.5–2.0)
VRE Time-to-bed-assignment Discontinuation Policy
Minutes
Adjustedd
Adjusted
OR (95%CI)e
PAM with >5 years of experience (N=149/231) 3.7 --
Large institution (N=88/230) 10.3 2.4 (1.2–4.9)*
Urban setting (N=144/233) 3.9 0.6 (0.3–1.2)
Cohorting patients permitted (N=60/215) 9.6 1.8 (0.9–3.6)
Mixed or double occupancy (N=158/231) 9.3 1.3 (0.7–2.6)

Note. Parameter estimates provided in minutes. MRSA, methicillin-resistant Staphylococcus aureus. VRE, vancomycin-resistant enterococcus. Large institution: >400 beds. Urban setting: >50,000 population.

*

P<0.05

**

P<0.01

a

N=x/y where x is the number of PAMs who reported the characteristic and y is the total number of PAMs who responded to the question.

b

Sample size for MRSA adjusted model was 176, with 57 responses deleted due to missing values.

c

Sample size for MRSA adjusted model was 189, with 44 responses deleted due to missing values.

d

Sample size for VRE adjusted model was 174, with 59 responses deleted due to missing values.

e

Sample size for VRE adjusted model was 191, with 42 responses deleted due to missing values.